Ranbaxy Opens New Manufacturing Facility in South Africa
September 7, 2010
Ranbaxy SA Pty has opened its new manufacturing facility, Be-Tabs Pharmaceuticals Manufacturing Plant, at Roodepoort, Johannesburg, South Africa. This is the company''s second manufacturing facility in South Africa and the third on the African continent. The new facility, built with an investment of $30 million will manufacture analgesics, cold, cough and flu preparations, anti-histamines, anti-hypertensives, central nervous system drugs, vitamins and minerals as well as a comprehensive range of over-the-counter medication. The products manufactured will comprise tablets and hard gelatin capsules. Ranbaxy said the plant is capable of producing approximately 1.75 billion units and packaging of two billion units, annually.